78.00
price up icon2.16%   1.75
 
loading

Illumina Inc Aktie (ILMN) Neueste Nachrichten

pulisher
10:55 AM

June 6th Options Now Available For Illumina (ILMN) - Nasdaq

10:55 AM
pulisher
10:26 AM

It’s all about accessibility: Developing technical training for the MiSeq i100 Series - Illumina

10:26 AM
pulisher
07:57 AM

Should You Hold Illumina (ILMN)? - Yahoo Finance

07:57 AM
pulisher
Apr 23, 2025

Veraxa makes a SPAC deal; Illumina discloses layoffs - Endpoints News

Apr 23, 2025
pulisher
Apr 22, 2025

Resmed Taps Illumina Exec for Chief Investor Relations Officer Role - Medical Product Outsourcing

Apr 22, 2025
pulisher
Apr 22, 2025

Microarray Market Projected To Witness Massive Growth, 2025-2032 | Thermo Fisher Scientific Inc.,Illumina Inc. - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

DNA Microarray Technology Market: Innovations & Opportunities - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Cancer Biopsy Market Detailed In New Research Report 2025 | - openPR.com

Apr 22, 2025
pulisher
Apr 22, 2025

Genomic Cancer Testing Market Overall Study Report 2025-2032 | - openPR.com

Apr 22, 2025
pulisher
Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025
pulisher
Apr 21, 2025

Thomas Kean Jr purchases shares in Illumina and nVent Electric - Investing.com Australia

Apr 21, 2025
pulisher
Apr 21, 2025

Resmed Names Salli Schwartz as Chief Investor Relations Officer - The Manila Times

Apr 21, 2025
pulisher
Apr 21, 2025

Resmed Names Salli Schwartz as Chief Investor Relations Officer - GlobeNewswire Inc.

Apr 21, 2025
pulisher
Apr 21, 2025

Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns - Insider Monkey

Apr 21, 2025
pulisher
Apr 21, 2025

Controlling Genes Market Detailed in New Research Report By 2032 - openPR.com

Apr 21, 2025
pulisher
Apr 18, 2025

Illumina (ILMN) Receives a Buy from Leerink Partners - The Globe and Mail

Apr 18, 2025
pulisher
Apr 18, 2025

Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive

Apr 18, 2025
pulisher
Apr 18, 2025

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks - Yahoo Finance

Apr 18, 2025
pulisher
Apr 17, 2025

DNA Methylation Market Deep Research Report with Forecast by 2032 | Illumina, Inc.,Thermo Fisher Scientific - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

RNA Sequencing Market Size, Share, Outlook, Industry Analysis, - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

MicroRNA Market Size, Share, Trends, Opportunities, - openPR.com

Apr 17, 2025
pulisher
Apr 16, 2025

AI in Omics Studies Market Overall Study Report 2025-2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina - openPR.com

Apr 16, 2025
pulisher
Apr 15, 2025

Illumina, Tempus AI To Collaborate To Accelerate Genomic AI Innovation - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus join forces to expand genomic testing By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina, Tempus AI Collaborating to Accelerate Clinical Use of Sequencing Tests - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina And Tempus Partner To Drive The Future Of Precision Medicine Through Genomic Ai Innovation - MarketScreener

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus join forces to expand genomic testing - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation - PR Newswire

Apr 15, 2025
pulisher
Apr 14, 2025

BofA Securities Cuts Price Target on Illumina to $75 From $90, Keeps Underperform Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 13, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Illumina, Inc.(ILMN) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 13, 2025
pulisher
Apr 13, 2025

Illumina (NASDAQ:ILMN) Price Target Cut to $112.00 by Analysts at Royal Bank of Canada - MarketBeat

Apr 13, 2025
pulisher
Apr 12, 2025

Illumina : Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development - MarketScreener

Apr 12, 2025
pulisher
Apr 11, 2025

Personalized Medicine Market Forecast Report and Company Analysis 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La RocheResearchAndMarkets.com | FinancialContent - FinancialContent

Apr 11, 2025
pulisher
Apr 10, 2025

Illumina To Announce First Quarter 2025 Financial Results On Thursday, May 8, 2025 - MarketScreener

Apr 10, 2025
pulisher
Apr 10, 2025

Shareholders in Illumina (NASDAQ:ILMN) have lost 77%, as stock drops 6.8% this past week - simplywall.st

Apr 10, 2025
pulisher
Apr 10, 2025

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Single-cell Omics Emerging Technologies and Markets Report 2025: 10x Genomics, Thermo Fisher & Illumina Lead $9.1 Billion Single-cell Omics Market by 2029 - Yahoo Finance

Apr 10, 2025
pulisher
Apr 10, 2025

Cancer Profiling Market Positioned for Accelerated Growth with - openPR.com

Apr 10, 2025
pulisher
Apr 10, 2025

Illumina (ILMN) Receives a Sell from Barclays - The Globe and Mail

Apr 10, 2025
pulisher
Apr 09, 2025

Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

Genotyping Assay Market Surges to USD 37.1 Billion by 2029: - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

Biotechnology company Illumina names Julie Hiner as comms head - Medical Marketing and Media

Apr 09, 2025
pulisher
Apr 09, 2025

PacBio to cut jobs, lower spending over NIH funding cuts and tariffs - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

DNA Data Storage Market to See Booming Growth 2025-2032 | Illumina, Inc.,Microsoft,Iridia, Inc.,Twist Bioscience - openPR.com

Apr 09, 2025
pulisher
Apr 08, 2025

DNA Sequencing Technologies Market Deep Research Report with - openPR.com

Apr 08, 2025
pulisher
Apr 08, 2025

Admera Health uses the NovaSeq X Plus to expand capabilities - Illumina

Apr 08, 2025
pulisher
Apr 08, 2025

RBC Cuts Price Target on Illumina to $112 From $128, Keeps Outperform Rating - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 08, 2025

Where are the Opportunities in (ILMN) - news.stocktradersdaily.com

Apr 08, 2025
pulisher
Apr 07, 2025

Deep Dive Into Illumina Stock: Analyst Perspectives (14 Ratings) - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

Apple To $250? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

How Do Investors Really Feel About Illumina? - Benzinga

Apr 07, 2025
pulisher
Apr 07, 2025

California Public Employees Retirement System Reduces Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat

Apr 07, 2025
pulisher
Apr 04, 2025

Epigenetics Market Deep Research 2025-2032 | Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited - openPR.com

Apr 04, 2025
pulisher
Apr 04, 2025

Illumina stock hits 52-week low at $70.88 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

INVESTOR ALERT: Levi & Korsinsky Notifies Illumina, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineILMN - ACCESS Newswire

Apr 04, 2025
diagnostics_research DGX
$173.97
price down icon 0.05%
diagnostics_research LH
$222.92
price down icon 0.56%
diagnostics_research WAT
$328.78
price down icon 1.78%
$149.19
price up icon 3.02%
diagnostics_research MTD
$1,044.96
price up icon 4.17%
diagnostics_research IQV
$146.54
price up icon 2.44%
Kapitalisierung:     |  Volumen (24h):